Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Early Breast Cancer peptide trials
2 selected ClinicalTrials.gov records carrying the official condition label Early Breast Cancer. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
2 selected records.
2 profiles.
2026–2026 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 78 selected PubMed records and 27 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Early Breast Cancer unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT07310420
PeptideScanner retained ClinicalTrials.gov record NCT07310420 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was goserelin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- November 12, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT05827081
PeptideScanner retained ClinicalTrials.gov record NCT05827081 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-13, and PeptideScanner's reviewed identity mapping was leuprolide.
- PeptideScanner change date
- November 14, 2026
- Cited source date
- November 13, 2026
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Leuprolide · 2026-11-13
ClinicalTrials.gov record NCT05827081
Active, not recruiting at the retained observation.
Open attributed record →Goserelin · 2026-11-12
ClinicalTrials.gov record NCT07310420
Recruiting at the retained observation.
Open attributed record →